- Home
- GURE vs SYRS Comparison
GURE vs SYRS Comparison
Compare GURE & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- SYRS
- Stock Information
- Founded
- GURE 2006
- SYRS 2011
- Country
- GURE China
- SYRS United States
- Employees
- GURE N/A
- SYRS N/A
- Industry
- GURE Major Chemicals
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- SYRS Health Care
- Exchange
- GURE Nasdaq
- SYRS Nasdaq
- Market Cap
- GURE 7.1M
- SYRS 5.7M
- IPO Year
- GURE 1992
- SYRS 2016
- Fundamental
- Price
- GURE $0.68
- SYRS $0.17
- Analyst Decision
- GURE
- SYRS Hold
- Analyst Count
- GURE 0
- SYRS 5
- Target Price
- GURE N/A
- SYRS $3.00
- AVG Volume (30 Days)
- GURE 251.5K
- SYRS 1.5M
- Earning Date
- GURE 11-19-2024
- SYRS 03-26-2025
- Dividend Yield
- GURE N/A
- SYRS N/A
- EPS Growth
- GURE N/A
- SYRS N/A
- EPS
- GURE N/A
- SYRS N/A
- Revenue
- GURE $12,802,982.00
- SYRS $386,000.00
- Revenue This Year
- GURE N/A
- SYRS N/A
- Revenue Next Year
- GURE N/A
- SYRS N/A
- P/E Ratio
- GURE N/A
- SYRS N/A
- Revenue Growth
- GURE N/A
- SYRS N/A
- 52 Week Low
- GURE $0.50
- SYRS $0.16
- 52 Week High
- GURE $1.79
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- GURE 49.72
- SYRS 33.17
- Support Level
- GURE $0.62
- SYRS $0.16
- Resistance Level
- GURE $0.73
- SYRS $0.20
- Average True Range (ATR)
- GURE 0.08
- SYRS 0.02
- MACD
- GURE -0.00
- SYRS 0.01
- Stochastic Oscillator
- GURE 50.00
- SYRS 10.34
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.